<?xml version="1.0" encoding="UTF-8"?>
<p id="Par11">In the Wuhan region of China, reports indicate PLWH have struggled to access ART during the COVID-19 outbreak due to the stigma and discrimination surrounding the HIV/AIDS epidemic in the country [
 <xref ref-type="bibr" rid="CR54">54</xref>]. While this has not been reported to date in the United States, there are growing concerns around overall prescription drug shortages due to drop-offs in production in China and India [
 <xref ref-type="bibr" rid="CR55">55</xref>]. If PLWH cannot access ART, their viremia will likely increase [
 <xref ref-type="bibr" rid="CR56">56</xref>], leading to lower CD4 T-cell counts [
 <xref ref-type="bibr" rid="CR57">57</xref>], an increased risk of developing opportunistic infections [
 <xref ref-type="bibr" rid="CR58">58</xref>], and an increased risk of HIV transmission to others. As such, it is imperative PLWH remain engaged with their primary and HIV healthcare providers amidst the COVID-19 pandemic to ensure consistent access to HIV-related care and treatment.
</p>
